EUS-guided Intratumoral Gemcitabine Therapy in Locally Advanced Unresectable Pancreatic Cancer: A Phase 1 Study
In this study, gemcitabine will be injected directly into the tumor by means of endoscopic
ultrasound (EUS) in the eligible patients.
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Number of participants with adverse events as a measure of safety and tolerability
Mehdi Mohamadnejad, M.D.
Digestive Disease Research Center, University of Tehran/Medical sciences
Iran: Ethics Committee